Adherence and population pharmacokinetic properties of amodiaquine when used for seasonal malaria chemoprevention in African children

Adherence and population pharmacokinetic properties of amodiaquine when used for seasonal malaria chemoprevention in African children

Poor adherence to seasonal malaria chemoprevention (SMC) might affect the protective effectiveness of SMC. Here, we evaluated the population pharmacokinetic properties of amodiaquine and its active metabolite, desethylamodiaquine, in children receiving SMC under directly observed ideal conditions (n...

Full description

Bibliographic Details
Main Authors:	Ding, J, Coldiron, ME, Assao, B, Guindo, O, Blessborn, D, Winterberg, M, Grais, RF, Koscalova, A, Langendorf, C, Tarning, J
Format:	Journal article
Language:	English
Published:	Wiley 2019

Similar Items

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
by: Matthew E. Coldiron, et al.
Published: (2021-10-01)

Pharmacokinetic considerations in seasonal malaria chemoprevention
by: Chotsiri, P, et al.
Published: (2022)

Seasonal malaria chemoprevention: successes and missed opportunities.
by: Coldiron, M, et al.
Published: (2017)

Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
by: Grais, R, et al.
Published: (2018)

Seasonal malaria chemoprevention: successes and missed opportunities
by: Matthew E. Coldiron, et al.
Published: (2017-11-01)

Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
by: Rebecca F. Grais, et al.
Published: (2018-02-01)

Clinical diagnostic evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria in an area receiving seasonal malaria chemoprevention in Niger
by: Matthew E. Coldiron, et al.
Published: (2019-12-01)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015)

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
by: Taiwo Ibinaiye, et al.
Published: (2023-05-01)

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali
by: Mahamadou A. Thera, et al.
Published: (2018-05-01)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.
by: Rijken, M, et al.
Published: (2011)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
by: Rijken, M, et al.
Published: (2011)

High-throughput quantitation method for amodiaquine and desethylamodiaquine in plasma using supported liquid extraction technology
by: Kaewkhao, K, et al.
Published: (2021)

Pharmacokinetics of intravenous amodiaquine.
by: White, N, et al.
Published: (1987)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.
by: Hamma Maiga, et al.
Published: (2016-01-01)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy
by: Tarning, J, et al.
Published: (2012)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
by: Almahamoudou Mahamar, et al.
Published: (2022-02-01)

Amodiaquine and malaria prophylaxis
by: Peto, T, et al.
Published: (1986)

POPULATION PHARMACOKINETICS OF ARTESUNATE AND AMODIAQUINE IN AFRICAN CHILDREN
by: Stepniewska, K, et al.
Published: (2008)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
by: Walimbwa, S, et al.
Published: (2018)

Population pharmacokinetics of artesunate and amodiaquine in African children.
by: Stepniewska, K, et al.
Published: (2009)

Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosing
by: Ali, A, et al.
Published: (2018)

Population pharmacokinetics of artesunate and amodiaquine in African children
by: Ouedraogo Alphonse, et al.
Published: (2009-08-01)

Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.
by: Looareesuwan, S, et al.
Published: (1985)

Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
by: Thomas A. Anyorigiya, et al.
Published: (2021-01-01)

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
by: Krishna, S, et al.
Published: (1996)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
by: Bergstrand, M, et al.
Published: (2014)

Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
by: J L NDiaye, et al.
Published: (2016-01-01)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
by: Mwesigwa, J, et al.
Published: (2010)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
by: Steve M Taylor, et al.
Published: (2022-10-01)

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
by: Theonest K Mutabingwa, et al.
Published: (2009-01-01)

Correction: Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
by: J L NDiaye, et al.
Published: (2016-01-01)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2019-01-01)

Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults
by: Banda, C, et al.
Published: (2018)

A new approach to evaluate stability of amodiaquine and its metabolite in blood and plasma.
by: Blessborn, D, et al.
Published: (2006)

Sub-national tailoring of seasonal malaria chemoprevention in Mali based on malaria surveillance and rainfall data
by: Mady Cissoko, et al.
Published: (2022-08-01)

Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry
by: Wongchang, T, et al.
Published: (2022)

Effect of routine seasonal malaria chemoprevention on malaria trends in children under 5 years in Dangassa, Mali
by: Drissa Konaté, et al.
Published: (2020-04-01)